ProfileGDS4132 / 240419_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 48% 51% 34% 35% 41% 50% 42% 41% 40% 38% 49% 51% 45% 39% 33% 41% 44% 44% 36% 42% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101127.45148
GSM201543Muscle PCOS pioglitazone 121129.66551
GSM201544Muscle PCOS pioglitazone 16186.549234
GSM201545Muscle PCOS pioglitazone 20196.891835
GSM201829Muscle PCOS pioglitazone 231115.10641
GSM201830Muscle PCOS pioglitazon 251138.550
GSM201831Muscle PCOS pioglitazone 271111.05742
GSM201832Muscle PCOS pioglitazone 31104.97941
GSM201833Muscle PCOS pioglitazone 4195.65940
GSM201834Muscle PCOS pioglitazone 8194.167638
GSM201835Muscle PCOS after pioglitazone 102117.36949
GSM201836Muscle PCOS after pioglitazone 122125.51651
GSM201837Muscle PCOS after pioglitazone 162100.96445
GSM201838Muscle PCOS after pioglitazone 20290.862139
GSM201839Muscle PCOS after pioglitazone 23275.797133
GSM201840Muscle PCOS after pioglitazone 252103.12241
GSM201841Muscle PCOS after pioglitazone 272100.95344
GSM201842Muscle PCOS after pioglitazone 3295.275344
GSM201843Muscle PCOS after pioglitazone 4290.068536
GSM201844Muscle PCOS after pioglitazone 82103.9242